EUVIMEDEUVIMED entdecken
Crossref

Serum CX3CL1/fractalkine concentrations are positively associated with disease severity in postmenopausal osteoporotic patients

Yi-Ding Chen, Ci-You Huang, Hai-Ying Liu, Wei-Feng Yao, Wei-Guo Wu, Yu-Lian Lu, Wen Wang

British Journal of Biomedical Science · 28.09.2016 · 73 (3) · 121-128

DOI: 10.1080/09674845.2016.1209897 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Biomedical Science, 2016-08. Verfasst von Yi-Ding Chen und 6 weiteren Autor:innen. Beteiligte Einrichtung: a Department of Endocrinology , Nanjing Medical University Affiliated Wuxi Second Hospital , Wuxi , China. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 47 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: The chemokine (C-X3-C motif) ligand 1 (CX3CL1), also called fractalkine (FKN), has recently been reported to be involved in osteoclastogenic process and pathological bone destruction. OBJECTIVE: This study aimed to investigate the link between serum CX3CL1/FKN levels with disease progression of postmenopausal osteoporotic patients. METHODS: A total of 53 women with postmenopausal osteoporosis (PMOP group), 51 postmenopausal non-osteoporotic female patients (PMNOP group) and 50 premenopausal non-osteoporotic healthy women of childbearing age (control group) were enrolled in the study. The bone mineral density (BMD) for all subjects was determined via dual-energy X-ray absorptiometry of the lumbar spine, femoral neck, internal trochanter, total hip, greater trochanter and Ward's triangle. The levels of FKN in the serum were examined using the enzyme-linked immunosorbent assay method. The serum bone resorption markers TRACP-5b, NTX levels, inflammation markers IL-1β and IL-6 as well as oestrogen-2(E2) were also detected in all participants. The visual analogue scores (VAS) and Oswestry Disability Index (ODI) for low back pain were recorded in PMOP females for evaluation of osteoporotic pain and function. RESULTS: FKN levels were significantly higher in postmenopausal osteoporotic patients compared with postmenopausal non-osteoporotic females (139.8 ± 44.3 pg/mL VS 116.5 ± 23.1 pg/mL, p < 0.05) and healthy controls (139.8 ± 44.3 pg/mL VS 109.7 ± 19.4 pg/mL, p < 0.05). Serum FKN concentrations were negatively associated with BMD at femoral neck (r = -0.394, p = 0.004), total hip(r = -0.374, p = 0.006), internal trochanter(r = -0.340, p = 0.013), greater trochanter(r = -0.376, p = 0.006), Ward's triangle(r = -0.343, p = 0.012), L1-L4 lumbar spine(r = -0.339, p = 0.013) and positively associated with VAS (r = 0.321, p = 0.019) and ODI (r = 0.377, p = 0.005) scores, bone turnover makers (TRACP-5b:r = 0.341, p = 0.012; NTX:r = 0.364, p = 0.007)as well as inflammation markers (IL-1β: r = 0.396, p = 0.003; IL-6:r = 0.355, p = 0.009) in postmenopausal osteoporotic patients. CONCLUSIONS: Serum FKN may serve as a novel biomarker for assessing disease progression and a new potential therapeutic target for anti-resorptive treatment in osteoporosis patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Absorptiometry, PhotonAgedBiomarkersBone DensityChemokine CX3CL1Disease ProgressionFemaleHumansLow Back PainMiddle AgedOsteoporosis, Postmenopausal

Stichwörter der Autor:innen

Osteoporosisdisease severityfractalkine

Substanzen

BiomarkersCX3CL1 protein, humanChemokine CX3CL1

Autor:innen und Institutionen

  • a Department of Endocrinology , Nanjing Medical University Affiliated Wuxi Second Hospital , Wuxi , China.
  • b Department of Nursing , Nanjing Medical University Affiliated Wuxi Second Hospital , Wuxi , China.

Zitieren

APA

Chen, Y. D., Huang, C. Y., Liu, H. Y., Yao, W. F., Wu, W. G., Lu, Y. L., & Wang, W. (2016). Serum CX3CL1/fractalkine concentrations are positively associated with disease severity in postmenopausal osteoporotic patients. British Journal of Biomedical Science, 73(3), 121-128. https://doi.org/10.1080/09674845.2016.1209897

Vancouver

Chen YD, Huang CY, Liu HY, Yao WF, Wu WG, Lu YL, et al. Serum CX3CL1/fractalkine concentrations are positively associated with disease severity in postmenopausal osteoporotic patients. British Journal of Biomedical Science. 2016;73(3):121-128. doi:10.1080/09674845.2016.1209897

BibTeX
@article{Chen2016,
  author = {Chen, Yi-Ding and Huang, Ci-You and Liu, Hai-Ying and Yao, Wei-Feng and Wu, Wei-Guo and Lu, Yu-Lian and Wang, Wen},
  title = {Serum CX3CL1/fractalkine concentrations are positively associated with disease severity in postmenopausal osteoporotic patients},
  journal = {British Journal of Biomedical Science},
  year = {2016},
  volume = {73},
  number = {3},
  pages = {121--128},
  doi = {10.1080/09674845.2016.1209897}
}
Kostenlos starten →